The Curtiss-Wright "Insider Sale" That Wasn't a Sale

The headline that landed on Thursday was the kind designed to make you look: a Curtiss-Wright executive vice president, John C. Watts, had "disposed of" $641,000 of the company's stock. That is a sentence with a built-in story. Someone high inside the company just got rid of a meaningful pile of shares, and selling is the thing insiders do when they think a stock has done its work.

Watts didn't sell anything. The Form 4 he filed with the SEC describes the disposal as a contribution to an exchange fund. That distinction is not paperwork pedantry; it changes what the trade means. Instead of selling 1,035 shares — valued at $619.46 apiece, the prior day's closing price — Watts dropped them into a private partnership, and took back units of the diversified pool. He got no cash. He realized no capital gain. And in the detail that should really retire the "he knows something" theory: his money is now locked up for seven years.

Here is what an exchange fund is. Under Section 721 of the tax code, moving appreciated stock into a partnership in exchange for partnership units is not treated as a sale. The gain sits there, undisturbed, and carries your original cost basis with it. Group a bunch of rich people with the same problem — tech founders sitting on one giant appreciated stock — into one partnership, and each of them trades their single-name bet for a claim on everybody else's single-name bets. Instant diversification, no tax event.

The IRS has spent decades making sure that trick doesn't become a free pass. To keep the deferral, the fund has to look like a real diversified vehicle, not a parking lot: it must hold at least 20% of its assets in non-securities such as real estate, and in practice it holds a big assortment of stocks so no one contributor's shares dominate. The seven-year minimum holding period is the load-bearing rule — leave early and the IRS can treat your contribution as a taxable sale, possibly returning your original stock and your tax bill along with it. You pay annual fees in the 0.4% to 1.5% range for this service, plus some, and it is only open to people rich enough to qualify. And the tax is deferred, not eliminated: when you eventually sell the fund's diversified basket, you pay capital gains on the appreciation since the day you contributed.

This is the least informative "insider sale" the market can generate, for mechanical reasons worth spelling out. A sale tells the market someone chose cash over their own stock at a price. An exchange-fund contribution tells you the opposite: the person who knows the company best chose a diversified basket over the stock he knows best, because his problem is concentration, not conviction. The contributed Curtiss-Wright shares don't even hit the secondary market — the fund is a sink, not a seller, so there is no selling pressure to read into. And the $641,000 figure is the value of what he moved around, not money that landed in his bank account.

The scale should also adjust your mental picture. That $641,000 was 0.003% of Curtiss-Wright's market capitalization — three-thousandths of one percent of the company's shares. Watts still owns 2,736 shares directly, worth around $1.7 million at recent prices. He has been trimming concentration on a schedule, too: in June he sold 200 shares at $770.56 through a pre-arranged trading plan, a kind of sale designed specifically to remove any informational content from the trade.

The larger context makes the move sensible rather than sinister. Curtiss-Wright is a diversified aerospace, defense and naval-industrial supplier that has roughly quintupled over five years, partly because investors re-rated it hard — reports had the price-to-earnings multiple stretching from about 20x into the mid-50s. Even after a sharp pullback it trades at roughly 40x trailing earnings, as a growth stock. If you are an executive who is paid in a stock that has done that, a large fraction of your net worth is one defense-cycle headline away from being halved, and selling costs you a fortune in capital gains tax. An exchange fund is the sensible, unglamorous answer: de-risk the household balance sheet, keep the tax deferral, and let the money work in a diversified wrapper for seven years.

That is the transaction as a transaction. What it does not do is tell you much about Curtiss-Wright the investment, and that is worth keeping separate. The company's actual numbers have been fine: second-quarter sales rose 5% to $924 million, operating margin expanded, earnings grew at a mid-teens clip, and management raised full-year guidance to 8-9% sales growth, 14-16% earnings-per-share growth, and a record $585-605 million of free cash flow. The stock fell anyway on the print — a slight revenue miss and some timing pressure in parts of the business — and this month it has been sliding from a 52-week high near $808 to the low $600s, YTD still positive and roughly 26% below that high.

So the honest reading is: an executive moving $641,000 of stock into a tax-deferred diversification vehicle, at a multiple that only makes sense if you believe the growth story, is an asset-allocation decision, not an information event. The people who cover this trade for clicks treat every Form 4 as a binary — insider sold, stock is doomed — but most insider selling is structural. Executives get paid in stock, and at some point they have to diversify; the rare signal worth watching is insiders buying. A contribution to a seven-year exchange fund is the furthest thing from that.

The question the exchange fund doesn't answer is the one that actually matters for the stock: is ~40x earnings the right price for a great business growing sales 8-9% a year? The EVP has decided he didn't want all of his eggs in that answer for the next seven years. That is a comment about his net worth, not about the company's. It doesn't make Curtiss-Wright a worse business; it doesn't make it cheaper either.